Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Retraction Notice: Examining the Potential of Machine Learning in Reducing Prescription Drug Costs
2
Zitationen
5
Autoren
2024
Jahr
Abstract
The ability of the system to gain knowledge for lowering prescription drug prices has been increasingly studied in recent years. Gadget-gaining knowledge is a branch of synthetic intelligence that enables machines and PC systems to enhance their overall performance on specific obligations by means of mastering beyond facts. Within the context of prescription drug costs, gadget learning may be used to find patterns and developments in drug pricing and usage, decide disparities in getting admission to and usage, and have a look at pricing strategies hired by pharmaceutical businesses. The use of gadgets to gain knowledge can help to discover elements using prescription drug costs, inclusive of the pricing and utilization of individual capsules or the relationships among drug costs and effects. Moreover, AI-primarily based algorithms may be used to use massive datasets in an effort to apprehend the role that healthcare vendors, insurers, and pharmaceutical organizations have on prescription drug costs.Moreover, AI-based total fashions can also be used to become aware of and degree cost elements associated with specific drug combinations. Sooner or later, machine studying may be leveraged to examine the effects of policy changes and healthcare reforms on prescription drug costs and to become aware of goal populations with high prescription drug prices. By combining gadget studying with conventional healthcare price analysis gear, researchers can gain insights into the drivers of prescription drug charges and make public coverage decisions. In sum, a device gaining knowledge can be a powerful tool.
Ähnliche Arbeiten
Adherence to Medication
2005 · 7.877 Zit.
Adherence to Long-Term Therapies: Evidence for Action
2003 · 6.304 Zit.
Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence
1986 · 5.283 Zit.
SF-36 Health Survey Update
2000 · 4.426 Zit.
Depression Is a Risk Factor for Noncompliance With Medical Treatment
2000 · 4.120 Zit.